Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 91-98

  Bao, Lingjie ^a,b   Jaramillo, Melba C ^c   Zhang, Zhenbo ^d   Zheng, Yunxi ^a,b   Yao, Ming ^e   Zhang, Donna D ^c   Yi, Xiaofang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF ARIZONA   (United States)

^d SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autophagy; Cisplatin; Ovarian carcinoma; Resistance

Indexed keywords

3 METHYLADENINE; BECLIN 1; CISPLATIN; MICROTUBULE ASSOCIATED PROTEIN 1; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC50; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENETICS; METABOLISM; OVARY TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84916201306     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2671     Document Type: Article

References (25)

1. Kim A, Ueda Y, Naka T and Enomoto T: Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 31: 14, 2012.
2. Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279, 2003.
3. Galluzzi L, Senovilla L, Vitale I, et al: Molecular mechanisms of cisplatin resistance. Oncogene 31: 1869-1883, 2012.
4. Carew JS, Nawrocki ST and Cleveland JL: Modulating auto phagy for therapeutic beneft. Autophagy 3: 464-467, 2007.
5. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
6. Eskelinen EL and Saftig P: Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793: 664-673, 2009
7. Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075, 2008.
8. Guo XL, Li D, Hu F, et al: Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 320: 171-179, 2012.
9. O'Donovan TR, O'Sullivan GC and McKenna SL: Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemo-therapeutics. Autophagy 7: 509-524, 2011.
10. Wu MY, Fu J, Xu J, O'Malley BW and Wu RC: Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor. Cell Res 22: 1003-1021, 2012.
11. Sirichanchuen B, Pengsuparp T and Chanvorachote P: Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells. Mol Cell Biochem 364: 11-18, 2012.
12. Bao LJ, Jaramillo MC and Zhang ZB, et al: Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma. Int J Clin Exp Pathol 7: 1502-1513, 2014.
13. Wang CY, Cusack JC Jr, Liu R and Baldwin AS Jr: Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 5: 412-417, 1999.
14. Gallego MA, Joseph B, Hemström TH, et al: Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas. Oncogene 23: 6282-6291, 2004.
15. Yu H, Su J, Xu Y, et al: p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiqui-tinated proteins. Eur J Cancer 47: 1585-1594, 2011.
16. Kihara A, Kabeya Y, Ohsumi Y and Yoshimori T: Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2: 330-335, 2001.
17. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
18. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G and Johansen T: p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145, 2007.
19. Mathew R, Karp CM, Beaudoin B, et al: Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075, 2009.
20. Seglen PO and Gordon PB: 3-Methyladenine: specifc inhibitor of autophagic/lysosomal protein degradation in isolated rat hepa-tocytes. Proc Natl Acad Sci USA 79: 1889-1892, 1982.
21. Stroikin Y, Dalen H, Lööf S and Terman A: Inhibition of autophagy with 3-methyladenine results in impaired turnover of lysosomes and accumulation of lipofuscin-like material. Eur J Cell Biol 83: 583-590, 2004.
22. Liu D, Yang Y, Liu Q and Wang J: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28: 105-111, 2011.
23. Zou Z, Wu L, Ding H, et al: MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing Beclin 1-mediated autophagy. J Biol Chem 287: 4148-4156, 2012.
24. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T and Kuwano H: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-771, 2009.
25. Zhu Y, Zhao L, Liu L, et al: Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell 1: 468-477, 2010.